Related Experiment Video
Updated: Oct 1, 2025

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Published on: June 24, 2025
Targeting Microbial Bio-film: an Update on MDR Gram-Negative Bio-film Producers Causing Catheter-Associated Urinary
Susmita Chakrabarty1, Monali P Mishra2, Dipankar Bhattacharyay3
1School of Paramedics and Allied Health Sciences, Centurion University of Technology and Management, Sitapur, Odisha, India.
Abstract:
In every age group, urinary tract infection (UTI) is found as a major recurrence infectious disorder. Bio-films produced by bacteria perform a vital role in causing infection in the tract of the urinary system, leading to recurrences and relapses. The purpose of this review is to present the role and mechanism of bio-film producing MDR Gram-negative bacteria causing UTI, their significance, additionally the challenges for remedy and prevention of catheter-associated UTI. This work appreciates a new understanding of bio-film producers which are having multi-drug resistance capability and focuses on the effect and control of bio-film producing uropathogenic bacteria related to catheterization. We have tried to analyze approaches to target bio-film and reported phytochemicals with anti-bio-film activity also updated on anti-bio-film therapy.
Insights
Urinary tract infections (UTIs) often recur due to biofilm-producing, multidrug-resistant (MDR) Gram-negative bacteria. This review explores their mechanisms, challenges in treating catheter-associated UTIs, and potential anti-biofilm therapies.
Area of Science:
- Microbiology
- Infectious Diseases
- Urology
Background:
- Urinary tract infections (UTIs) are a significant cause of recurrent infectious disease across all age groups.
- Bacterial biofilms play a crucial role in the pathogenesis of UTIs, leading to persistent infections, recurrences, and relapses.
- Catheter-associated UTIs (CAUTIs) represent a major challenge in healthcare settings.
Purpose of the Study:
- To review the role and mechanisms of biofilm-producing multidrug-resistant (MDR) Gram-negative bacteria in causing UTIs.
- To highlight the significance of these bacteria and the challenges in treating and preventing CAUTIs.
- To explore novel strategies targeting biofilms and discuss phytochemicals with anti-biofilm activity.
Main Methods:
- Literature review focusing on biofilm formation by uropathogenic bacteria.
- Analysis of MDR Gram-negative bacteria associated with UTIs and CAUTIs.
- Compilation of data on anti-biofilm approaches and phytochemical interventions.
Main Results:
- Biofilm production by MDR Gram-negative bacteria is a key factor in recurrent and persistent UTIs, particularly CAUTIs.
- Understanding biofilm mechanisms is essential for developing effective treatment and prevention strategies.
- Phytochemicals show promise as potential agents against biofilm formation.
Conclusions:
- Targeting bacterial biofilms is critical for managing recurrent UTIs and CAUTIs.
- Further research into anti-biofilm therapies, including phytochemicals, is warranted.
- Effective control of biofilm-producing uropathogenic bacteria is necessary to improve patient outcomes.
Related Concept Videos
Biofilms
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Gene Regulation in Microbial Communities: Quorum Sensing
Urinary Tract Infection II: Pathophysiology

